Jeffcoate W J, Lipsky B A, Berendt A R, Cavanagh P R, Bus S A, Peters E J G, van Houtum W H, Valk G D, Bakker K
Foot Ulcer Trials Unit, Nottingham University Hospitals Trust, Nottingham, UK.
Diabet Med. 2008 Dec;25(12):1380-9. doi: 10.1111/j.1464-5491.2008.02573.x.
Management of diabetic foot ulcers presents a major clinical challenge. The response to treatment is often poor and the outcome disappointing, while the costs are high for both healthcare providers and the patient. In such circumstances, it is essential that management should be based on firm evidence and follow consensus. In the case of the diabetic foot, however, clinical practice can vary widely. It is for these reasons that the International Working Group on the Diabetic Foot has published guidelines for adoption worldwide. The Group has now also completed a series of non-systematic and systematic reviews on the subjects of soft tissue infection, osteomyelitis, offloading and other interventions designed to promote ulcer healing. The current article collates the results of this work in order to demonstrate the extent and quality of the evidence which is available in these areas. In general, the available scientific evidence is thin, leaving many issues unresolved. Although the complex nature of diabetic foot disease presents particular difficulties in the design of robust clinical trials, and the absence of published evidence to support the use of an intervention does not always mean that the intervention is ineffective, there is a clear need for more research in the area. Evidence from sound clinical studies is urgently needed to guide consensus and to underpin clinical practice. It is only in this way that patients suffering with these frequently neglected complications of diabetes can be offered the best hope for a favourable outcome, at the least cost.
糖尿病足溃疡的管理是一项重大的临床挑战。治疗反应往往不佳,结果令人失望,而医疗服务提供者和患者的成本都很高。在这种情况下,管理必须基于确凿的证据并遵循共识。然而,在糖尿病足的情况下,临床实践差异很大。正是由于这些原因,国际糖尿病足工作组发布了供全球采用的指南。该小组现在还完成了一系列关于软组织感染、骨髓炎、减负及其他旨在促进溃疡愈合的干预措施的非系统性和系统性综述。本文整理了这项工作的结果,以展示这些领域现有证据的范围和质量。总体而言,现有的科学证据不足,许多问题尚未解决。尽管糖尿病足病的复杂性在设计有力的临床试验时带来了特殊困难,而且缺乏支持使用某种干预措施的已发表证据并不总是意味着该干预措施无效,但该领域显然需要更多研究。迫切需要来自可靠临床研究的证据来指导共识并支撑临床实践。只有这样,患有这些经常被忽视的糖尿病并发症的患者才能以最低的成本获得取得良好结果的最大希望。